ASX 200

Its troubles may be over for now but a US$55 billion belting in its share price suggests investors have already made up their mind.

Metro and Arrow among the few ASX stocks offering leveraged exposure; Plus, Spartan and Rumble take the week’s gold honours.

In this episode, David Keelan from Ellerston and Andrew Peros from Ausbil analyse a handful of the ASX's market darlings.

What the market is missing on Origin Energy

When will lithium prices finally turn around? We pinpoint when the lithium market will swing back to a deficit, and therefore higher prices.

We unpack UBS' bullish thesis for gold, and leverage insights from Livewire to assess the five stocks it likes.

Shares of Pro Medicus, Technology One, Wisetech Global and Xero have soared in 2024, but how much upside remains for those who invest now?

This $60m ASX-listed biotech, with a cutting-edge pipeline of transformative therapies, stands at a key inflection point for value creation.

Lithium minerals markets have been dynamic over the past few weeks, with prices staging a modest rally. We check up on the key developments.

Generative AI assistants are rapidly improving. We investigate how one assistant can help investors understand complicated investing jargon.

Our guest for this Ep is Jennifer Westacott AO & what a conversation it is – an inspiring story of one of Australia’s leading women.

High quality companies have been repeat M&A targets of late. This wire details the material demand for high quality assets across sectors

You'll find out in this episode of Buy Hold Sell.

Milford's Dynamic Small Companies Fund has delivered investors 5.35% of outperformance p.a. since 2019. Here are the stocks they're backing.

With the S&P/ASX 200 hitting new highs, we ask “What’s in store for 2025?” How much higher can Aussie shares go!?

MD says Honeymoon project in South Australia is well on track to hit guidance; Plus, Argonaut’s latest list of best undeveloped projects.

In this episode, David Keelan from Ellerston and Andrew Peros from Ausbil analyse some of the ASX's top small caps.

Uranium is rallying on the US election result and Russia’s export ban. If the low is in, these are the global & ASX uranium stocks to watch.

Its model portfolio may have underperformed the benchmark by 2.25%, but Morgan Stanley's sell-side team are holding firm to their call.

Hear Michael, Co-Founder of Collins St AM, explain how hands-on research & real-world insights uncover hidden value in Aussie equities.

The investment world has become hyper-concentrated, so where can investors turn for uncorrelated returns?

The uranium price is looking up after Trump’s big US election win, and following a new ban on Russian enriched uranium exports to the US.

Firetrail's Australian Small Companies Fund has shot the lights out over the past 12 months. Here, they reveal the stocks they are backing.

Perpetual's Anthony Aboud argues shorting decisions should be more than valuation based and shares the opportunities he's watching.